Skip to main content
Livermore
Livermore
ZHEN

Checkpoint Therapeutics, Inc.

CKPTDelisted May 30, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001651407

Checkpoint Therapeutics, Inc. was delisted on May 30, 2025; its insiders filed their last Form 4 on Jun 3, 2025; 84 institutions reported holding it in 13F filings for Q1 2025, worth $137.7M in total; no superinvestor held it.

13F holders, Q4 2022

Institutional positions in Checkpoint Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
40
−14 vs. Q3 2022
Shares held
1.91M
+1.03M (+116.0%) vs. Q3 2022Converted for a 1-for-10 split
Total value
$9.12M
+$19.0K (+0.2%) vs. Q3 2022
New holders
9
14 more added
Sold out
23
8 more reduced

3 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CKPT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 40 institutions
Q1 2021: 71 institutionsQ2 2021: 70 institutionsQ3 2021: 68 institutionsQ4 2021: 62 institutionsQ1 2022: 67 institutionsQ2 2022: 62 institutionsQ3 2022: 57 institutionsQ4 2022: 40 institutionsQ1 2023: 34 institutionsQ2 2023: 35 institutionsQ3 2023: 39 institutionsQ4 2023: 43 institutionsQ1 2024: 39 institutionsQ2 2024: 45 institutionsQ3 2024: 47 institutionsQ4 2024: 68 institutionsQ1 2025: 84 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2022: $9.12M
Q1 2021: $50.9MQ2 2021: $32.5MQ3 2021: $34.9MQ4 2021: $33.4MQ1 2022: $22.8MQ2 2022: $10.3MQ3 2022: $11.7MQ4 2022: $9.12MQ1 2023: $3.76MQ2 2023: $6.51MQ3 2023: $6.68MQ4 2023: $11.2MQ1 2024: $11.0MQ2 2024: $12.6MQ3 2024: $17.2MQ4 2024: $35.5MQ1 2025: $137.7MQ2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding CKPT and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 202584$137.7M
Q4 202468$35.5M
Q3 202447$17.2M
Q2 202445$12.6M
Q1 202439$11.0M
Q4 202343$11.2M
Q3 202339$6.68M
Q2 202335$6.51M
Q1 202334$3.76M
Q4 202240$9.12M
Q3 202257$11.7M
Q2 202262$10.3M
Q1 202267$22.8M
Q4 202162$33.4M
Q3 202168$34.9M
Q2 202170$32.5M
Q1 202171$50.9M

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Checkpoint Therapeutics, Inc.; share changes are against Q3 2022.

Institutions holding CKPT in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Armistice Capital, LLC691,895$3.54M0.10%+691,895New
Vanguard Group Inc301,937$1.54M0.00%00.0%UnchangedConverted for a 1-for-10 split
Bank of America Corp202,460$1.03M0.00%+201,460+20,142.0%AddedConverted for a 1-for-10 split
BlackRock Inc.95,869$489.9K0.00%00.0%UnchangedConverted for a 1-for-10 split
Geode Capital Management, LLC71,590$365.0K0.00%+2,048+2.9%AddedConverted for a 1-for-10 split
PVG Asset Management Corp54,983$281.0K1.24%+15,746+40.1%AddedConverted for a 1-for-10 split
Royal Bank of Canada48,163$246.0K0.00%+35,511+280.7%AddedConverted for a 1-for-10 split
Park Avenue Securities LLC46,545$238.0K0.00%+35,527+322.5%AddedConverted for a 1-for-10 split
Millennium Management LLC36,878$188.0K0.00%−18,301−33.2%ReducedConverted for a 1-for-10 split
Advisor Group Holdings, Inc.34,153$175.0K0.00%+9,959+41.2%AddedConverted for a 1-for-10 split
Envestnet Asset Management Inc27,805$142.1K0.00%+18,221+190.1%AddedConverted for a 1-for-10 split
Apollon Wealth Management, LLC26,358$134.7K0.01%+13,423+103.8%AddedConverted for a 1-for-10 split
Susquehanna International Group, LLP24,029$122.8K0.00%+22,724+1,740.9%AddedConverted for a 1-for-10 split
National Asset Management, Inc.19,150$97.9K0.00%+3,500+22.4%AddedConverted for a 1-for-10 split
State Street Corp18,807$96.1K0.00%−1,911−9.2%ReducedConverted for a 1-for-10 split
Ironwood Investment Management LLC12,564$64.2K0.04%−1,326−9.5%ReducedConverted for a 1-for-10 split
Northern Trust Corp11,513$58.8K0.00%00.0%UnchangedConverted for a 1-for-10 split
Jane Street Group, LLC10,042$51.3K0.00%+3,880+63.0%AddedConverted for a 1-for-10 split
Telemetry Investments, L.L.C.10,000$51.0K0.12%+10,000New
Tower Research Capital LLC (TRC)9,548$49.0K0.00%+9,104+2,052.4%AddedConverted for a 1-for-10 split
Emfo, LLC7,795$39.8K0.04%−11,330−59.2%ReducedConverted for a 1-for-10 split
Bartlett & Co. LLC5,000$26.0K0.00%00.0%UnchangedConverted for a 1-for-10 split
Bartlett & Co. Wealth Management LLC5,000$25.6K0.00%00.0%UnchangedConverted for a 1-for-10 split
Group One Trading, L.P.4,602$23.5K0.00%−1,277−21.7%ReducedConverted for a 1-for-10 split
UBS Group AG3,803$19.4K0.00%+731+23.8%AddedConverted for a 1-for-10 split
Morgan Stanley1,163$5.94K0.00%−1,499−56.3%ReducedConverted for a 1-for-10 split
FMR LLC889$4.54K0.00%+889New
Tradition Wealth Management, LLC686$4.00K0.00%00.0%UnchangedConverted for a 1-for-10 split
Lakewood Asset Management LLC580$3.00K0.00%+580New
Rockefeller Capital Management L.P.529$2.00K0.00%00.0%UnchangedConverted for a 1-for-10 split
TSFG, LLC300$2.00K0.00%00.0%UnchangedConverted for a 1-for-10 split
Trustcore Financial Services, LLC155$7920.00%00.0%UnchangedConverted for a 1-for-10 split
Belpointe Asset Management LLC85$4350.00%+85New
Citadel Advisors LLC64$3270.00%−1,598−96.1%ReducedConverted for a 1-for-10 split
Fortis Capital Advisors, LLC52$2660.00%+52New
Wells Fargo & Company49$2500.00%+1+2.7%AddedConverted for a 1-for-10 split
GWM Advisors LLC11,000$560.00%+11,000New
Sofos Investments, Inc.5$460.00%+5New
JPMorgan Chase & Co1$00.00%−1−47.4%ReducedConverted for a 1-for-10 split
Twinbeech Capital LP113,152––+113,152New
Lindbrook Capital, LLC0$00.00%−300−100.0%Sold outConverted for a 1-for-10 split
Renaissance Technologies LLC0$00.00%−35,750−100.0%Sold outConverted for a 1-for-10 split
Gsa Capital Partners LLP0$00.00%−34,986−100.0%Sold outConverted for a 1-for-10 split
Raymond James Financial Services Advisors, Inc.0$00.00%−8,256−100.0%Sold outConverted for a 1-for-10 split
Two Sigma Advisers, LP0$00.00%−8,010−100.0%Sold outConverted for a 1-for-10 split
Atom Investors LP0$00.00%−6,873−100.0%Sold outConverted for a 1-for-10 split
Price T Rowe Associates Inc0$00.00%−5,900−100.0%Sold outConverted for a 1-for-10 split
Two Sigma Investments, LP0$00.00%−4,610−100.0%Sold outConverted for a 1-for-10 split
Bank of New York Mellon Corp0$00.00%−4,232−100.0%Sold outConverted for a 1-for-10 split
Charles Schwab Investment Management Inc0$00.00%−3,371−100.0%Sold outConverted for a 1-for-10 split
Occidental Asset Management, LLC0$00.00%−2,640−100.0%Sold outConverted for a 1-for-10 split
Segall Bryant & Hamill, LLC0$00.00%−2,500−100.0%Sold outConverted for a 1-for-10 split
Joule Financial, LLC0$00.00%−1,882−100.0%Sold outConverted for a 1-for-10 split
Eqis Capital Management, Inc.0$00.00%−1,791−100.0%Sold outConverted for a 1-for-10 split
Financial Advocates Investment Management0$00.00%−1,500−100.0%Sold outConverted for a 1-for-10 split
Truist Financial Corp0$00.00%−1,396−100.0%Sold outConverted for a 1-for-10 split
Commonwealth Equity Services, LLC0$00.00%−1,440−100.0%Sold outConverted for a 1-for-10 split
D. E. Shaw & Co., Inc.0$00.00%−1,076−100.0%Sold outConverted for a 1-for-10 split
Level Four Advisory Services, LLC0$00.00%−1,000−100.0%Sold outConverted for a 1-for-10 split
Beirne Wealth Consulting Services, LLC0$00.00%−1,000−100.0%Sold outConverted for a 1-for-10 split
BNP Paribas Arbitrage, SA0$00.00%−98−100.0%Sold outConverted for a 1-for-10 split
First Manhattan Co0$00.00%−100−100.0%Sold outConverted for a 1-for-10 split
Baader Bank INC0$00.00%−8,820−100.0%Sold outConverted for a 1-for-10 split
Morgan Jess S & Co Inc––––Not filed
Spotlight Asset Group, Inc.––––Not filed
ACG Wealth––––Not filed